How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

6,977 results for

Renin-Angiotensin System

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

181. Renin-Angiotensin System and Cardiovascular Functions Full Text available with Trip Pro

Renin-Angiotensin System and Cardiovascular Functions 29950386 2018 11 14 1524-4636 38 7 2018 Jul Arteriosclerosis, thrombosis, and vascular biology Arterioscler. Thromb. Vasc. Biol. Renin-Angiotensin System and Cardiovascular Functions. e108-e116 10.1161/ATVBAHA.118.311282 Wu Chia-Hua CH From the Saha Cardiovascular Research Center (C.-H.W., S.M., J.Z.C., H.S., A.D., H.S.L.). Department of Pharmacology and Nutritional Sciences (C.-H.W., S.M., A.D., H.S.L.). Mohammadmoradi Shayan S From (...) Jan;38(1):143-153 29097367 Arterioscler Thromb Vasc Biol. 2017 Jan;37(1):26-34 27879251 Arterioscler Thromb Vasc Biol. 2016 Nov;36(11):2158-2162 27562915 Hypertension. 2008 May;51(5):1306-11 18391092 Arterioscler Thromb Vasc Biol. 2015 Aug;35(8):1826-34 26044581 Atherosclerosis. 2008 Oct;200(2):410-6 18262533 Arterioscler Thromb Vasc Biol. 2017 Mar;37(3):553-566 28062506 Nat Genet. 2012 Jul 08;44(8):916-21 22772371 Arterioscler Thromb Vasc Biol. 2017 Apr;37(4):694-706 28153878 J Renin Angiotensin

2018 Arteriosclerosis, thrombosis, and vascular biology

182. Renal Denervation Prevents Heart Failure Progression Via Inhibition of the Renin-Angiotensin System. Full Text available with Trip Pro

Renal Denervation Prevents Heart Failure Progression Via Inhibition of the Renin-Angiotensin System. Previously, we have shown that radiofrequency (RF) renal denervation (RDN) reduces myocardial infarct size in a rat model of acute myocardial infarction (MI) and improves left ventricular (LV) function and vascular reactivity in the setting of heart failure following MI.The authors investigated the therapeutic efficacy of RF-RDN in a clinically relevant normotensive swine model of heart failure (...) coronary artery responses to vasodilators.RF-RDN provides a novel therapeutic strategy to reduce renal sympathetic activity, inhibit the renin-angiotensin system, increase circulating B-type natriuretic peptide levels, attenuate LV fibrosis, and improve left ventricular performance and coronary vascular function. These cardioprotective mechanisms synergize to halt the progression of HFrEF following MI/R in a clinically relevant model system.Copyright © 2018 American College of Cardiology Foundation

2018 Journal of the American College of Cardiology

183. Use of renin-angiotensin-aldosterone system inhibitors and risks of COVID-19

Use of renin-angiotensin-aldosterone system inhibitors and risks of COVID-19 Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email

2020 PROSPERO

184. Individual patient data meta-analysis of renin-angiotensin-aldosterone system inhibitors in COVID-19

Individual patient data meta-analysis of renin-angiotensin-aldosterone system inhibitors in COVID-19 Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2020 PROSPERO

185. The effects of renin-angiotensin-aldosterone system (RAAS) inhibitors on severity or mortality in patients with COVID-19: a meta-analysis

The effects of renin-angiotensin-aldosterone system (RAAS) inhibitors on severity or mortality in patients with COVID-19: a meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration

2020 PROSPERO

186. Renin Angiotensin System in Women Using Combined Oral Contraceptives

Renin Angiotensin System in Women Using Combined Oral Contraceptives Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation

2020 PROSPERO

187. Efficacy of the renin-angiotensin system inhibitors for hypertrophic cardiomyopathy: an meta-analysis

Efficacy of the renin-angiotensin system inhibitors for hypertrophic cardiomyopathy: an meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2020 PROSPERO

188. Efficacy of renin-angiotensin system inhibitors on the severity and risk of death in patients with hypertension for coronavirus disease 2019 (covid-19): a systematic review and meta-analysis

Efficacy of renin-angiotensin system inhibitors on the severity and risk of death in patients with hypertension for coronavirus disease 2019 (covid-19): a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility

2020 PROSPERO

189. Renin-angiotensin-aldosterone system (RAAS) inhibitors and COVID-19 mortality in patients with hypertension hospitalized for COVID-19: a systematic review and meta-analysis

Renin-angiotensin-aldosterone system (RAAS) inhibitors and COVID-19 mortality in patients with hypertension hospitalized for COVID-19: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability

2020 PROSPERO

190. Renin-angiotensin-aldosterone system (RAAS) inhibitor use and COVID-19 disease severity

Renin-angiotensin-aldosterone system (RAAS) inhibitor use and COVID-19 disease severity Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites

2020 PROSPERO

191. Comparative effectiveness of renin-angiotensin system inhibitors on renal and cardiovascular outcomes in patients with diabetes and kidney disease: a network meta-analysis

Comparative effectiveness of renin-angiotensin system inhibitors on renal and cardiovascular outcomes in patients with diabetes and kidney disease: a network meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability

2020 PROSPERO

192. Impact of renin-angiotensin-aldosterone system inhibitors on mortality in hypertensive patients with COVID-19: systematic review and meta-analysis

Impact of renin-angiotensin-aldosterone system inhibitors on mortality in hypertensive patients with COVID-19: systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2020 PROSPERO

193. A systematic review and meta-analysis of observational studies on the safety of renin-angiotensin system (RAS) blockers (angiotensin-converting enzyme (ACE) inhibitors and angiotensin-receptor blockers (ARBs)) in relation to the likelihood of infection wi

A systematic review and meta-analysis of observational studies on the safety of renin-angiotensin system (RAS) blockers (angiotensin-converting enzyme (ACE) inhibitors and angiotensin-receptor blockers (ARBs)) in relation to the likelihood of infection wi Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied

2020 PROSPERO

194. Association between early worsening renal function and following Outcomes in patients with renin angiotensin system inhibitors treatment: A Meta-Analysis

Association between early worsening renal function and following Outcomes in patients with renin angiotensin system inhibitors treatment: A Meta-Analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2020 PROSPERO

195. The tissue renin-angiotensin system (tRAS) and the impact of its inhibition on inflammation and bone loss in the periodontal tissue: A systematic review and network meta-analysis of animal studies

The tissue renin-angiotensin system (tRAS) and the impact of its inhibition on inflammation and bone loss in the periodontal tissue: A systematic review and network meta-analysis of animal studies Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears

2020 PROSPERO

196. The efficacy and safety of renin-angiotensin-aldosterone system inhibitors for the prevention or slowing of diabetic nephropathy in patients with diabetes: A meta-analysis study

The efficacy and safety of renin-angiotensin-aldosterone system inhibitors for the prevention or slowing of diabetic nephropathy in patients with diabetes: A meta-analysis study Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability

2020 PROSPERO

197. Traumatic brain injury and drugs acting on the renin angiotensin system as potential treatment: a systematic review

Traumatic brain injury and drugs acting on the renin angiotensin system as potential treatment: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated

2020 PROSPERO

198. Combination use of medicines from different classes of renin-angiotensin system blocking agents: risk of hyperkalaemia, hypotension, and impaired renal function?new warnings

Combination use of medicines from different classes of renin-angiotensin system blocking agents: risk of hyperkalaemia, hypotension, and impaired renal function?new warnings Combination use of medicines from different classes of renin-angiotensin system blocking agents: risk of hyperkalaemia, hypotension, and impaired renal function—new warnings - GOV.UK GOV.UK uses cookies to make the site simpler. or Search Combination use of medicines from different classes of renin-angiotensin system (...) blocking agents: risk of hyperkalaemia, hypotension, and impaired renal function—new warnings New warnings due to risk of hyperkalaemia, hypotension, and impaired renal function have been agreed following an EU-wide review. Published 11 December 2014 From: Therapeutic area: , , Contents Article date: June 2014 The renin-angiotensin hormone system (RAS) controls blood pressure and the volume of fluids in the body. Medicines that have an inhibitory action on the RAS (RAS blocking agents) are used

2014 MHRA Drug Safety Update

199. Effects of renal denervation on cardiac oxidative stress and local activity of the sympathetic nervous system and renin-angiotensin system in acute myocardial infracted dogs. Full Text available with Trip Pro

Effects of renal denervation on cardiac oxidative stress and local activity of the sympathetic nervous system and renin-angiotensin system in acute myocardial infracted dogs. This study sought to evaluate the therapeutic effects of renal denervation (RDN) on acute myocardial infarction (MI) in canines and explore its possible mechanisms of action.Eighteen healthy mongrel dogs were randomly assigned to either the control group, the MI group or the MI + RDN group. To assess cardiac function, left (...) ) and activity of superoxide dismutase (SOD). To measure the local activity of the sympathetic nervous system (SNS) and renin-angiotensin system (RAS), the levels of tyrosine hydroxylase (TH), angiotensin II (AngII), angiotensin-converting enzyme 2 (ACE2), angiotensin (1-7) [Ang(1-7)] and Mas receptor (MasR) in myocardial tissues were recorded. The expression of TH in renal tissue and serum creatinine were used to assess the effectiveness of the RDN procedure and renal function, respectively.We found that MI

2017 BMC Cardiovascular Disorders

200. Cohort study: Renin-angiotensin system blockers increase risk of angio-oedema

Cohort study: Renin-angiotensin system blockers increase risk of angio-oedema Renin-angiotensin system blockers increase risk of angio-oedema | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers of institutional accounts Username (...) * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Renin-angiotensin system blockers increase risk of angio-oedema Article Text Aetiology Cohort study Renin-angiotensin system blockers increase risk of angio-oedema Massimo Volpe , Giuliano Tocci Statistics from Altmetric.com Commentary on: Toh S

2013 Evidence-Based Medicine

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>